We are live on
!
Find out more
LCM
Lazari Capital Management Portfolio holdings
AUM
$325M
1-Year Est. Return
32.83%
This Fund
S&P 500
This Quarter
Est. Return
+5.31%
1 Year Est. Return
+32.83%
3 Year Est. Return
+124.01%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$234M
AUM Growth
+$12M
(+5.4%)
Cap. Flow
+$1.94M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
53.11%
Holding
163
New
19
Increased
64
Reduced
60
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wynn Resorts
WYNN
|
+$1.88M |
| 2 |
Walt Disney
DIS
|
+$739K |
| 3 |
NVIDIA
NVDA
|
+$607K |
| 4 |
Microsoft
MSFT
|
+$302K |
| 5 |
iShares US Healthcare ETF
IYH
|
+$295K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$906K |
| 2 |
Altria Group
MO
|
+$749K |
| 3 |
Meta Platforms (Facebook)
META
|
+$653K |
| 4 |
Apple
AAPL
|
+$605K |
| 5 |
Invesco QQQ Trust
QQQ
|
+$442K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.31% |
| 2 | Communication Services | 19.02% |
| 3 | Consumer Discretionary | 11.37% |
| 4 | Financials | 7.19% |
| 5 | Energy | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Butterfly Network
BFLY
$2.58B
| $33.1K | 0.01% |
18,720
-2,500
| -12% | -$3.13K |
|
|
LAZR
152
DELISTED
Luminar Technologies
LAZR
| $14.7K | 0.01% |
1,087
| – | – |
|
153
Vivani Medical
VANI
$122M
| $11.7K | 0.01% |
+10,000
| New | +$12.5K |
|
154
TMC The Metals Company
TMC
$1.92B
| $10.6K | ﹤0.01% |
+10,000
| New | +$11.2K |
|
155
X4 Pharmaceuticals
XFOR
$421M
| $8.7K | ﹤0.01% |
433
+33
| +8% | +$689 |
|
156
Stem
STEM
$50.9M
| $4.38K | ﹤0.01% |
629
-25
| -4% | -$393 |
|
157
FuelCell Energy
FCEL
$1.59B
| $4.29K | ﹤0.01% |
377
| – | – |
|
|
ZOM
158
DELISTED
Zomedica Corp.
ZOM
| $1.37K | ﹤0.01% |
10,000
| – | – |
|
159
Freeport-McMoran
FCX
$98.7B
| – | – |
-4,381
| Closed | -$213K |
|
160
FedEx
FDX
$76.9B
| – | – |
-698
| Closed | -$209K |
|
|
FLG
161
Flagstar Bank National Association
FLG
$5.84B
| – | – |
-5,075
| Closed | -$49K |
|
|
ASXC
162
DELISTED
Asensus Surgical, Inc.
ASXC
| – | – |
-70,000
| Closed | -$23.3K |
|
Similar funds
WG
THCM
AC
DMC
KL
AIA
CWM
UOC
Lazari Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Lazari Capital Management held 163 positions worth $234M, up 5.4% from $222M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Lazari Capital Management's Q3 2024 filing shows 19 new, 64 increased, 60 reduced and 4 closed positions. Its largest new stake was iShares US Healthcare ETF: 4,610 shares worth $300K. The largest sale was Gilead Sciences, an estimated $906K.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Lazari Capital Management's largest Q3 2024 buy was iShares US Healthcare ETF: 4,610 shares worth $300K.
- Lazari Capital Management added most to Wynn Resorts in Q3 2024, an estimated $1.88M increase.
- Lazari Capital Management's biggest Q3 2024 reduction was Gilead Sciences, cutting an estimated $906K.
- Lazari Capital Management fully exited Freeport-McMoran in Q3 2024, selling an estimated $213K.
- Lazari Capital Management's ten largest holdings make up 53% of its $234M portfolio in Q3 2024.
- Lazari Capital Management opened 19 new positions and closed 4 in Q3 2024.
- Lazari Capital Management's portfolio value rose 5.4% quarter-over-quarter to $234M.
Based on Lazari Capital Management's 13F filing for Q3 2024, filed 22 Oct 2024.